Anivamersen

DB16089InvestigationalNucleic Acid Based Therapies

Anivamersen is under investigation in clinical trial NCT01848106 (A Study to Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI).

Also known as
Rna, (cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm)
Code names
RB-007

Resolves to

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Anivamersen, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account